XML 33 R2.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 43,337 $ 49,331
Marketable securities 38,669 68,735
Tax incentive receivable 235 1,536
Prepaid expenses and other current assets 1,202 1,728
Total current assets 83,443 121,330
Property and equipment, net 913 375
Operating lease right-of-use assets 7,172  
Restricted cash 1,339  
Other assets 20 57
Total assets 92,887 121,762
Current liabilities:    
Accounts payable 3,319 3,590
Accrued expenses 1,719 4,261
Accrued restructuring costs 3,619  
Operating lease liabilities, current 409  
Notes payable, current 7,273 5,455
Total current liabilities 16,339 13,306
Notes payable, long-term 10,166 15,185
Operating lease liabilities 6,502  
Total liabilities 33,007 28,491
Commitments and contingencies (Note 7)
Stockholders' equity:    
Preferred stock; $0.001 par value per share; 5,000,000 shares authorized as of September 30, 2019 and December 31, 2018; no shares issued and outstanding as of September 30, 2019 and December 31, 2018
Common stock, $0.001 par value per share; 115,000,000 shares authorized as of September 30, 2019 and December 31, 2018; 37,370,301 and 37,287,221 shares issued and outstanding as of September 30, 2019 and December 31, 2018, respectively 37 37
Additional paid-in capital 448,902 444,212
Accumulated deficit (389,100) (350,945)
Accumulated other comprehensive income (loss) 41 (33)
Total stockholders' equity 59,880 93,271
Total liabilities and stockholders' equity $ 92,887 $ 121,762